CClinicalTrials.gg
Status unknownNCT02052817Updated Feb 3, 2014

Randomized, Prospective Evaluation of the Toad Brace in Plantar Ulcer Off-loading and Healing

An interventional study of Optimal Medical Therapy Debridement + Toad Brace and Optimal Medical Therapy - Debridement in Diabetic Foot and Pedal Ulcers, sponsored by Toad Medical Corporation. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-02-03.

Sponsored by Toad Medical Corporation · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2014), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
74
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The TOAD Medical Corporation Brace is a novel device that completely off-loads the foot and has been shown to heal ulcers at a rapid rate in preliminary experience in patients with plantar ulcers. This trial will attempt to show the efficacy of the Toad Brace and is based on the hypothesis that the Toad brace completely offloads the foot and hastens healing rates of diabetic ulcers. The trial will randomize 74 patients with diabetic pedal ulcers to the Toad Brace or conventional therapy. . Quantitative assessment of ulcer rate healing rates will be determined clinically and by blinded, computer-assisted planimetry of digital images over a 12 week period. The pressure on the plantar surface will be measured via a pressure sensor in a subset of patients. The trials will attempt to show markedly reduced pressure on the plantar surface and significantly higher ulcer healing rates with using the Toad Brace.

02

Conditions studied

  • Diabetic Foot
  • Pedal Ulcers
03

In context

Diabetic Foot

1,054 studies on the registry are indexed under Diabetic Foot; 222 are open to participants now.

This study's planned enrollment of 74 is above the median of 60 across 826 interventional studies indexed under Diabetic Foot.

Browse Diabetic Foot studies →

Lead sponsor

This is the only study on the registry with Toad Medical Corporation as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Men or women >18 years old
  • One or more foot ulcers without clinical evidence of osteomyelitis
  • Diagnosis of Diabetes Mellitus*
  • University of Texas Grade 1A, 1C, 2A, or 2C ulcer15
  • ABI >0.7 and Toe pressure >30mmHg

Exclusion criteria

Exclusion Criteria:

  • Limited life-expectancy
  • Wounds on calf or shin that would be in contact with the TAG Brace
  • Gangrene, active infection
  • Osteomyelitis of the foot with the ulcer
  • Chronically bedridden/Non ambulatory
  • Unable to keep research appointments
  • Wide spread malignancy or systemically immunocompromising disease
  • Ipsilateral revascularization procedure within the last 30 days.
  • Unreliable, unwilling or unable to comprehend informed consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
74 participants (estimated)

Study arms

  • Active comparator
    Control

    Debridement and standard of care in off-loading on control patients

    Other: Optimal Medical Therapy - Debridement

  • Experimental
    Toad Brace

    Debridement and fitting of Toad Brace

    Device: Optimal Medical Therapy Debridement + Toad Brace

Interventions

  • DeviceOptimal Medical Therapy Debridement + Toad Brace
  • OtherOptimal Medical Therapy - Debridement
06

What researchers measure

Primary outcomes

  1. Change from baseline measured wound area

    We are taking repeated measures of wound area healing for pedal ulcers over a period of 12 weeks.

    Time frame: Every 3 weeks for a period of 12 weeks

07

Study locations

1 of 1 sites recruiting
  • UH Hospitals of Cleveland d/b/a University Hospitals Case Medical
    Cleveland, Ohio 44106, United States
    • Vikram S Kashyap, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02052817
Lead sponsor
Toad Medical Corporation
Collaborators
University Hospitals Cleveland Medical Center
Responsible party
Sponsor
First posted
Feb 3, 2014
Start date
Dec 2013
Primary completion
May 2014 (estimated)
Last update
Feb 3, 2014

Study contacts

Lori Hammer, RN
Contact
lori.hammer@uhhospitals.org
216-983-4719

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion